The Road Ahead: Expert Perspectives on Recent Therapeutic Advances in Small-Cell Lung Cancer

Get up to date on the optimal treatment of extensive-stage SCLC with this expert-led educational program featuring a ClinicalThought commentary on what’s new going into 2024 and 2 CME-certified text modules with downloadable slidesets capturing the standard of care and what’s on the horizon.

Share

Program Content

Activities

SoC Tx Advanced SCLC Module
Standard-of-Care Therapy in Advanced SCLC
Text Module
Congratulations: You achieved a completion on 04/09/2022

Released: March 29, 2024

Expires: March 28, 2025

Tx Advances SCLC Module
Recent Therapeutic Advances in Advanced SCLC
Text Module
Congratulations: You achieved a completion on 04/09/2022

Released: March 26, 2024

Expires: March 25, 2025

Activities

SoC Tx Advanced SCLC Slides
Standard of Care Therapy in Advanced SCLC
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: March 22, 2024

Expires: March 21, 2025

Tx Advances SCLC Slides
Recent Therapeutic Advances in Advanced SCLC
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: March 25, 2024

Expires: March 24, 2025

Activities

New Tx for Relapsed SCLC
What’s New in the Treatment of Relapsed SCLC
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: January 22, 2024

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC.

Supporters

Supported by an educational grant from Amgen and AstraZeneca Pharmaceuticals.

Amgen

AstraZeneca Pharmaceuticals